Home/Cardurion Pharmaceuticals/Charlotte Newman

CN

Charlotte Newman

Chief Business & Operations Officer

Cardurion Pharmaceuticals

Therapeutic Areas

Cardiovascular Heart Failure Arrhythmias

Cardurion Pharmaceuticals Pipeline

Drug	Indication	Phase
PDE9 Inhibitor	Heart Failure (HFrEF and HFpEF)	Clinical
CaMKII Inhibitor	Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), Heart Failure, Atrial Fibrillation	Clinical

Leadership Team at Cardurion Pharmaceuticals

Peter S. Lawrence, J.D.

President and CEO

Michael E. Mendelsohn, M.D.

Founder and Chief Strategy Officer

Howard K. Surks, M.D.

Chief Medical and Scientific Officer

Elizabeth Radcliffe

Chief Financial Officer

View full Cardurion Pharmaceuticals profile